Swk Holdings Corp. logo

Swk Holdings Corp. (SWKH)

Market Closed
5 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
17. 04
-0.1
-0.58%
$
207.09M Market Cap
13.8 P/E Ratio
0% Div Yield
2,724 Volume
1.85 Eps
$ 17.14
Previous Close
Day Range
16.71 17.27
Year Range
12.28 17.9
Want to track SWKH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SWKH closed yesterday lower at $17.04, a decrease of 0.58% from Thursday's close, completing a monthly increase of 1.07% or $0.18. Over the past 12 months, SWKH stock gained 32.71%.
SWKH is not paying dividends to its shareholders.
The last earnings report, released on Nov 13, 2025, missed the consensus estimates by -0.34%. On average, the company has surpassed earnings expectations by 0.11%, based on the last three reports.
Swk Holdings Corp. has completed 1 stock splits, with the recent split occurring on Oct 07, 2015.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on NASDAQ (NMS) (USD).

SWKH Chart

Stanley Black & Decker, Inc. (SWK) Presents at Goldman Sachs Industrials and Materials Conference 2025 Transcript

Stanley Black & Decker, Inc. (SWK) Presents at Goldman Sachs Industrials and Materials Conference 2025 Transcript

Stanley Black & Decker, Inc. (SWK) Presents at Goldman Sachs Industrials and Materials Conference 2025 Transcript

Seekingalpha | 2 days ago
Why Is Stanley Black & Decker (SWK) Up 4.2% Since Last Earnings Report?

Why Is Stanley Black & Decker (SWK) Up 4.2% Since Last Earnings Report?

Stanley Black & Decker (SWK) reported earnings 30 days ago. What's next for the stock?

Zacks | 2 days ago
Stanley Black & Decker, Inc. (SWK) Presents at Baird 55th Annual Global Industrial Conference Transcript

Stanley Black & Decker, Inc. (SWK) Presents at Baird 55th Annual Global Industrial Conference Transcript

Stanley Black & Decker, Inc. ( SWK ) Baird 55th Annual Global Industrial Conference November 12, 2025 1:35 PM EST Company Participants Christopher Nelson - President, CEO & Director Conference Call Participants Timothy Wojs - Robert W. Baird & Co. Incorporated, Research Division Presentation Timothy Wojs Robert W.

Seekingalpha | 3 weeks ago

Swk Holdings Corp. (SWKH) FAQ

What is the stock price today?

The current price is $17.04.

On which exchange is it traded?

Swk Holdings Corp. is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is SWKH.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 207.09M.

Has Swk Holdings Corp. ever had a stock split?

Swk Holdings Corp. had 1 splits and the recent split was on Oct 07, 2015.

Swk Holdings Corp. Profile

- Industry
- Sector
Jody. D Staggs CEO
NASDAQ (NMS) Exchange
78501P203 CUSIP
US Country
24 Employees
- Last Dividend
7 Oct 2015 Last Split
22 Sep 1999 IPO Date

Overview

SWK Holdings Corporation, headquartered in Dallas, Texas, is a specialized financial service and asset management firm operating predominantly within the United States. Initially known as Kana Software, Inc., the company underwent a name change to SWK Holdings Corporation in December 2009. Since its inception in 1996, SWK Holdings has distinguished itself by focusing on the life sciences sector, providing a unique blend of financial solutions and services to a diversified client base. The company functions through two main divisions: Finance Receivables and Pharmaceutical Development, catering to a wide array of needs in the life science community, including biotechnology, medical devices, diagnostics, animal health, and pharmaceuticals.

Products and Services

  • Finance Receivables

    This segment of SWK Holdings offers tailored financing solutions targeting a broad spectrum of life science companies and inventors. The clientele encompasses entities from the biotechnology, medical device, diagnostics, animal health, and pharmaceutical industries, among others. By providing flexible financing options, SWK Holdings supports the growth and advancement of companies and technologies within these sectors. Additionally, this segment extends non-discretionary investment advisory services to institutional clients, managing accounts specifically geared towards investments in life science finance.

  • Pharmaceutical Development

    SWK Holdings' Pharmaceutical Development segment delivers wide-ranging services in pharmaceutical development, formulation, and manufacturing. It is notably recognized for the Peptelligence platform, a proprietary oral drug delivery technology that offers innovative formulation solutions. The segment’s capabilities facilitate the development process for clients, from conceptualization to final product creation, encompassing both development services and formulation technologies. Furthermore, SWK Holdings engages in the intellectual property licensing business, leveraging its developments and technologies to establish partnerships and collaborations within the industry.

Contact Information

Address: 14755 Preston Road
Phone: 972 687 7250